Skip to main content
Premium Trial:

Request an Annual Quote

Finnish Biotech to Use Waban s Software; IBM to Manage Service

This article corrects a headline that mistakenly reported that a Finnish biotech will use Waban's software. In fact, GeneOS will use Waban's software.

NEW YORK, Aug. 5 (GenomeWeb News) - Finnish biotech GeneOS will use Waban's software to help it build and couple patients' longitudinal healthcare data with information from blood samples, the companies said today.

The company will use Waban's biological sample and laboratory management, and data analysis and reporting system to create a centralized databank to "support the clinical and operational need" of GeneOS for collecting patient medical history, drug history, and genetic data into "specific biohealth databases," Waban said.

The software will be deployed on GeneOS' servers, which are managed by IBM Hosting Services in
Helsinki. IBM will provide technical and operation support, security enhanced networking to GeneOS and hospitals, and control the servers, Waban said.


Financial details of the deal were not disclosed.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.